Skip to main content
PMC home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2002 Nov 12;7(4):187–210. doi: 10.1016/0166-3542(87)90028-3

Bovine interferon: Its biology and application in veterinary medicine

HBielefeldt Ohmann 1,a, MJP Lawman 1, LA Babiuk 1
PMCID: PMC7133961  PMID: 2441661

Abstract

Investigations of the production and potential use of bovine interferons against viral infections have occurred since the first descriptions of interferons in other systems. The recent advent of recombinant DNA-technology has facilitated such studies and furthered our knowledge about the bovine interferon system in general. This review gives an overview of the biology, antiviral and immunomodulatory activities of bovine interferons. Areas in which the interferons are now applied or have potential application in viral diseases in cattle are described. Finally, the value of studies of the bovine interferon system with respect to comparative interferon research is discussed.

Keywords: Interferon, Bovine, Antiviral effect, Immunomodulation, Recombinant interferon

References

  • 1.Ahl R. Production and regulation of synthesis of interferon in bovine kidney cell cultures. Dev. Biol. Standard. 1982;50:159–166. [PubMed] [Google Scholar]
  • 2.Ahl R., Gottschalk M. Purification and characterization of bovine interferon β. In: Cancellotti F.M., Galassi D., editors. Adjuvants, Interferon and Non-specific Immunity. Second ed. 1984. pp. 31–37. (Comm. Eur. Commun.). (Eur 8675EN) [Google Scholar]
  • 3.Ahl R., Rump A. Assay of bovine interferons in cultures of the porcine cell line IB-RS-2. Infect. Immun. 1976;14:603–606. doi: 10.1128/iai.14.3.603-606.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Anderson K., Czarniecki C., McCracken J., Bielefeldt Ohmann H., Babiuk L.A. Second ed. 1985. The potential uses of bovine interferon for bovine respiratory disease; pp. 39–54. (Proc. 4th Vet. Resp. Symp., Anaheim, CA). [Google Scholar]
  • 5.Angulo A.B., Savan M. Proc. 74th Annu. Meet. U.S. Anim. Health Assoc. 1970. Preliminary studies in interferon induction in the respiratory tract of cattle; pp. 577–583. [Google Scholar]
  • 6.Aune T.M., Pierce C.W. Second ed. Vol. 79. 1982. Activation of a suppressor T-cell pathway by interferon; pp. 3808–3812. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Bakiuk L.A. Second ed. Academic Press; New York: 1984. Virus-induced gastroenteritis in animals; pp. 349–363. (Appl. Virol.). [Google Scholar]
  • 7.Babiuk L.A., Rouse B.T. Immune interferon production by lymphoid cells role in the inhibition of herpesviruses. Infect. Immun. 1976;13:1567–1578. doi: 10.1128/iai.13.6.1567-1578.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Babiuk L.A., Rouse B.T. Bovine type II interferon: activity in heterologous cells. Intervirology. 1977;8:250–256. doi: 10.1159/000148900. [DOI] [PubMed] [Google Scholar]
  • 9.Babiuk L.A., Rouse B.T. Interactions between effector cell activity and lymphokines: implications for the recovery from herpesvirus infections. Int. Arch. Allergy Appl. Immunol. 1978;57:62–73. doi: 10.1159/000232085. [DOI] [PubMed] [Google Scholar]
  • 10.Babiuk L.A., Bielefeldt Ohmann H. Effect of levamisole and bovine interferonα1, on bovine immune responses and susceptibility to bovine herpesvirus-1. Prog. Clin. Biol. Res. 1984;161:433–442. [PubMed] [Google Scholar]
  • 11.Babiuk L.A., Bielefeldt Ohmann H., Gifford G., Czarniecki C.W., Scialli V.T., Hamilton E.B. Effect of bovineα1, interferon on bovine herpes type-1-induced respiratory disease. J. Gen. Virol. 1985;66:2383–2394. doi: 10.1099/0022-1317-66-11-2383. [DOI] [PubMed] [Google Scholar]
  • 12.Babiuk L.A., Sabara m., Hudson G.R. Rotavirus and coronavirus infections in animals. Prog. Vet. Microbiol. Immunol. 1985;Vol. 1:80–120. [PubMed] [Google Scholar]
  • 13.Baglioni C. Interferon-induced enzymatic activites and their role in the antiviral state. Cell. 1979;17:255–264. doi: 10.1016/0092-8674(79)90151-x. [DOI] [PubMed] [Google Scholar]
  • 14.Baglioni C., Benvin S., Maroney P.A., Minks M.A., Nilsen T.W., West D.K. Interferon-induced enzymes: activation and role in the antiviral state. Ann. N.Y. Acad. Sci. 1980;350:497–509. doi: 10.1111/j.1749-6632.1980.tb20652.x. [DOI] [PubMed] [Google Scholar]
  • 15.Baglioni C., Nilsen T.W. The action of interferon at the molecular level. Sci. Am. 1981;69:392–399. 1981. [PubMed] [Google Scholar]
  • 16.Bell D.M., Roberts N.J., Hall C.B. Different antiviral spectra of human macrophages interferon activites. Nature (London) 1983;305:319–321. doi: 10.1038/305319a0. [DOI] [PubMed] [Google Scholar]
  • 17.Bielefeldt Ohmann H., Babiuk L.A. Effect of bovine recombinant alpha-1 interferon on inflammatory responses of bovine phagocytes. J. Interferon Res. 1984;4:249–263. doi: 10.1089/jir.1984.4.249. [DOI] [PubMed] [Google Scholar]
  • 18.Bielefeldt Ohmann H., Babiuk L.A. Alteration of neutrophil function after in vitro and in vivo exposure to recombinant bovine interferon alpha or -gamma. J. Leuk. Biol. 1985;38:165. (abstract) [Google Scholar]
  • 19.Bielefeldt Ohmann H., Babiuk L.A. In vitro and systemic effects of recombinant bovine interferons on natural cell-mediated cytotoxicity in healthy and bovine herpesvirus-1 infected cattle. J. Interferon Res. 1985;5:551–564. doi: 10.1089/jir.1985.5.551. [DOI] [PubMed] [Google Scholar]
  • 20.Bielefeldt Ohmann H., Babiuk L.A. Viral-bacterial pneumonia in calves: effect of bovine herpesvirus-1 on immunologic functions. J. Infect. Dis. 1985;151:937–947. doi: 10.1093/infdis/151.5.937. [DOI] [PubMed] [Google Scholar]
  • 21.Bielefeldt Ohmann H., Babiuk L.A. Proc. 1st Intern. Vet. Immunol. Symp. Guelph; Ontario: 1986. Alteration of alveolar macrophage functions by in vivo treatment with recombinant interferons alpha-1 and gamma; p. 71. [Google Scholar]
  • 22.Bielefeldt Ohmann H., Babiuk L.A. Alteration of some leukocyte functions following in vivo and in vitro exposure to recombinant bovine interferon α1, and γ. J. Interferon Res. 1986;6:123–136. doi: 10.1089/jir.1986.6.123. [DOI] [PubMed] [Google Scholar]
  • 23.Bielefeldt Ohmann H., Babiuk L.A. Viral infections of domestic animal as models for studies of viral immunology and pathogenesis. J. Gen. Virol. 1986;67:1–25. doi: 10.1099/0022-1317-67-1-1. [DOI] [PubMed] [Google Scholar]
  • 24.Bielefeldt Ohmann H., Davis W.C., Babiuk L.A. Functional and phenotypic characteristics of bovine natural cytotoxicity cells. Immunobiology. 1985;169:503–519. doi: 10.1016/S0171-2985(85)80005-X. [DOI] [PubMed] [Google Scholar]
  • 25.Bielefeldt Ohmann H., Davis W.C., Babiuk L.A. Surface antigen expression by bovine alveolar macrophages: functional correlation and influence of interferons in vivo and in vitro. Immunobiology. 1986;171:125–142. doi: 10.1016/s0171-2985(86)80022-5. [DOI] [PubMed] [Google Scholar]
  • 26.Bielefeldt Ohmann H., Gilchrist J.E., Babiuk L.A. Effect of recombinant DNA-produced bovine interferon alpha (BoIFN-α) on the interaction between bovine alveolar macrophages and bovine herpesvirus type 1. J. Gen. Virol. 1984;65:1487–1495. doi: 10.1099/0022-1317-65-9-1487. [DOI] [PubMed] [Google Scholar]
  • 27.Billiau A., Heremans H., Allen P.T., DeMaeyer-Guignard J., DeSomer P. Trapping of coronavirus particles at the surface of interferon-treated cells. Virology. 1976;73:537–542. doi: 10.1016/0042-6822(76)90416-5. [DOI] [PubMed] [Google Scholar]
  • 28.Biron C.A., Welsh R.M. Activation and role of natural killer cells in virus infections. Med. Microbiol. Immunol. 1982;170:155–172. doi: 10.1007/BF02298196. [DOI] [PubMed] [Google Scholar]
  • 29.Bouffard A., Derbyshire J.B. Effects of some components of the humoral immune response on the replication of bovine herpesvirus type 1 in tracheal organ cultures. Vet. Microbiol. 1981;6:129–141. doi: 10.1016/0378-1135(82)90037-2. [DOI] [PubMed] [Google Scholar]
  • 30.Brochier B., Werenne J., Goossens A., Vanden Broecke C., Derbove G., Pastoret P.P. In vitro effect of bacterially produced human interferon (Hu-IFN-α2) on non-specific blastogenesis in the bovine species. In: Cancellotti F.M., Galassi D., editors. Adjuvants, Interferon and Non-specific Immunity. Second ed. 1984. pp. 59–63. (Comm. Eur. Comm.). (Eur 8675EN) [Google Scholar]
  • 31.Capon D.J., Shepard H.M., Goeddel D.V. Two distinct families of human and bovine interferon-α genes are coordinately expressed and encode functional polypeptides. Mol. Cell. Biol. 1985;5:768–779. doi: 10.1128/mcb.5.4.768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Cerretti D.P., McKereghan K., Larsen A., Cosman D., Gillis S., Baker P.E. Cloning, sequence and expression of bovine interferon-γ. J. Immunol. 1986;136:4561–4564. [PubMed] [Google Scholar]
  • 33.Cummins J.M., Rosenquist B.D. Leukocyte changes and interferon production in calves injected with hydrocortisone and infected with infectious bovine rhinotracheitis virus. Am. J. Vet. Res. 1979;40:239–240. [PubMed] [Google Scholar]
  • 34.Cummins J.M., Rosenquist B.D. Protection of calves against rhinovirus infection by nasal secretion interferon induced by infectious bovine rhinotracheitis virus. Am. J. Vet. Res. 1980;41:161–165. 1980. [PubMed] [Google Scholar]
  • 35.Cummins J.M., Rosenquist B.D. Temporary protection of calves against adenovirus infection by nasal secretion interferon induced by infectious bovine rhinotracheitis virus. Am. J. Vet. Res. 1982;43:955–959. [PubMed] [Google Scholar]
  • 36.Cummins J.M., Rosenquist B.D. Partial protection of calves against parainfluenza-3 virus infection by nasal secretion interferon induced by infectious bovine rhinotracheitis virus. Am. J. Vet. Res. 1982;43:1334–1338. [PubMed] [Google Scholar]
  • 37.Czarniecki C.W., Hamilton E.B., Fennie C.W., Wolf R.L. In vitro biological activities for Escherichia coli-derived bovine interferons and interferons -α1, -β and γ. J. Interferon Res. 1986;6:29–37. doi: 10.1089/jir.1986.6.29. [DOI] [PubMed] [Google Scholar]
  • 38.Dagenais L., Pastoret P.P., van den Broecke C., Werenne J. Susceptibility of bovine rotavirus to interferon. Arch. Virol. 1981;70:377–379. doi: 10.1007/BF01320253. [DOI] [PubMed] [Google Scholar]
  • 39.Davis W.C. The use of monoclonal antibodies to define the bovine lymphocyte antigen system BoLA leukocyte differentiation antigens, and other polymorphic antigens. In: Davis W.C., Shelton J.N., Weems C.W., editors. Characterization of the bovine immune system and the genes regulating expression of immunity with particular reference to their role in disease resistance. Second ed. 1984. (Proc. Symp. May 1–5. Honolulu, Hawaii). [Google Scholar]
  • 40.DeMaeyer E., DeMaeyer-Guignard J. Host genotype influences immunomodulation by interferon. Nature. 1980;284:173–175. doi: 10.1038/284173a0. [DOI] [PubMed] [Google Scholar]
  • 41.DeMaeyer E., DeMaeyer-Guignard J. Immunomodulating properties of interferons. Philos. Trans. R. Soc. London, Ser. B. 1982;299:77–90. doi: 10.1098/rstb.1982.0108. [DOI] [PubMed] [Google Scholar]
  • DeMaeyer-Guignard J.D., Cachard A., DeMaeyer E. Electrophoretically pure mouse interferon has priming but not blocking activity in poly (I.C.)-induced cells. Virology. 1980;102:222–225. doi: 10.1016/0042-6822(80)90085-9. [DOI] [PubMed] [Google Scholar]
  • 42.Diderholm H., Dinter Z. Second ed. Vol. 121. 1966. Interference between strains of bovine virus diarrhea virus and their capacity to suppress interferon of a heterologous virus; pp. 976–980. (Proc. Soc. Exp. Biol. Med.). [DOI] [PubMed] [Google Scholar]
  • 43.Dziewanowska Z.E., Pestka S. The human interferons. Med. Res. Rev. 1982;2:325–353. doi: 10.1002/med.2610020403. [DOI] [PubMed] [Google Scholar]
  • 44.El Azhary M.A.S.Y., Silim A., Roy R.S. Interferon, fluorescent antibody and neutralizing antibody responses in sera of calves inoculated with bovine respiratory syncytial virus. Am. J. Vet. Res. 1981;42:1378–1382. [PubMed] [Google Scholar]
  • 45.Engler H., Zawatzky R., Kirchner H., Armerding D. Experimental infection of inbred mice with herpes simplex virus. IV. Comparison of interferon production and natural killer cell activity in susceptible and resistant adult mice. Arch. Virol. 1982;74:239–247. doi: 10.1007/BF01314157. [DOI] [PubMed] [Google Scholar]
  • 46.Filion L., Bielefeldt Ohmann H., Owen P.W., Babiuk L.A. Characterization of the bovine secondary in vitro antibody response. Vet. Immunol. Immunopathol. 1984;7:19–32. doi: 10.1016/0165-2427(84)90024-2. [DOI] [PubMed] [Google Scholar]
  • 47.Forman A.J., Babiuk L.A. Effect of infectious bovine rhinotracheitis virus infection on bovine alveolar macrophage function. Infect. Immun. 1982;35:1041–1047. doi: 10.1128/iai.35.3.1041-1047.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Friedman R.M. Second ed. Acad. Press; N.Y: 1981. (Interferon: A Primer.). [Google Scholar]
  • 49.Fulton R.W., Downing M.M., Cummins J.M. Antiviral effects of bovine interferons on bovine respiratory tract viruses. J. Clin. Microbiol. 1984;19:492–497. doi: 10.1128/jcm.19.4.492-497.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Fulton R.W., Pearson N.J. Interferon production by bovine tracheal organ cultures infected with bovid herpesvirus-1 strains. Can. J. Comp. Med. 1980;44:447–452. [PMC free article] [PubMed] [Google Scholar]
  • 51.Fulton R.W., Pearson N.J. Interferon induction in bovine and feline monolayer cultures by four bluetongue virus serotypes. Can. J. Comp. Med. 1982;46:100–102. [PMC free article] [PubMed] [Google Scholar]
  • 52.Fulton R.W., Root S.K. Antiviral activity in interferon-treated bovine tracheal organ cultures. Infect. Immun. 1978;21:672–673. doi: 10.1128/iai.21.2.672-673.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Fulton R.W., Rosenquist B.D. In vitro interferon production by bovine tissues: induction with infectious bovine rhinotracheitis virus. Am. J. Vet. Res. 1976;37:1497–1502. [PubMed] [Google Scholar]
  • 54.Gillespie J.H., Robson D.S., Scott F.W., Schiff E.I. In vitro protective effect of bacteria-derived bovine alpha interferon Ii against selected bovine viruses. J. Clin. Microbiol. 1985;22:912–914. doi: 10.1128/jcm.22.6.912-914.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Goossens A., van den Broecke C., Schwers A., Dagenais L., Maenhoudt M., Pastoret P.P., Werenne J. In vitro antiviral efficiency of bacterially produced human interferon (HuIFNα2) against several bovine viruses. In: Cancellotti F.M., Galassi D., editors. Adjuvants, Interferon and Non-specific Immunity. Second ed. 1984. pp. 37–44. (Comm. Eur. Comm.). (EUR 8675EN) [Google Scholar]
  • 56.Gresser I., editor. Second ed. Acad. Press; London: 1979–2000. (Interferon). [Google Scholar]
  • 57.Gresser I., Tovey M.G., Maury C., Bandu M.T. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease and influenza viruses. J. Exp. Med. 1976;144:1316–1327. doi: 10.1084/jem.144.5.1316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Hiscott J., Cantell K., Weissman C. Differential expression of human interferon genes. Nucleic Acids Res. 1984;12:3727–3746. doi: 10.1093/nar/12.9.3727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Isaacs A., Burke D.C. Mode of actions of interferon. Nature. 1958;182:1073–1074. doi: 10.1038/1821073a0. [DOI] [PubMed] [Google Scholar]
  • 60.Isaacs A., Lindenmann J. Second ed. Vol. 147. 1957. Virus interference. I. The interferon; pp. 258–267. (Proc. R. Soc. London, Ser. B.). [Google Scholar]
  • 61.Jay F.T., Dawood M.R., Friedman R.M. Interferon induces the production of membrane protein deficient and infectivity defective vesicular stomatitis virions through interference in the virion assembly process. J. Gen. Virol. 1983;64:707–712. doi: 10.1099/0022-1317-64-3-707. [DOI] [PubMed] [Google Scholar]
  • 62.Knight D.J., Ashton R.J. Induction of circulating interferon in calves with 3 different types of double stranded ribonucleic acid. Res. Vet. Sci. 1980;28:386–388. [PubMed] [Google Scholar]
  • 63.Kiderlen A.F., Kaufmann S.H.E., Lohmann-Matthes M.L. Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon. Eur. J. Immunol. 1984;14:964–967. doi: 10.1002/eji.1830141019. [DOI] [PubMed] [Google Scholar]
  • 64.Kierszenbaum F., Sonnenfeld G. β-interferon inhibits cell infection by Trypanosoma cruzi. J. Immunol. 1984;132:905–908. [PubMed] [Google Scholar]
  • 65.Kirchner H. Interferons, a group of multiple lymphokines. Spring Sem. Immunopathol. 1984;7:347–374. doi: 10.1007/BF00201966. [DOI] [PubMed] [Google Scholar]
  • 66.Kono Y. Second ed. Vol. 124. 1967. Rapid production of interferon in bovine leukocyte cultures; pp. 155–160. (Proc. Soc. Exp. Biol. Med.). [DOI] [PubMed] [Google Scholar]
  • 67.La Bonnardiere C., Cohen J., Contrepois M. Interferon activity in rotavirus infected newborn calves. Ann. Rech. Vet. 1981;12:85–91. [PubMed] [Google Scholar]
  • 68.La Bonnardiere C., Laude H. Interferon induction in rotavirus and coronavirus infections: A review of recent results. Ann. Rech. Vet. 1983;14:507–511. [PubMed] [Google Scholar]
  • 69.La Bonnardiere C., De Vaureix C., L'Haridon R., Scherber R. Weak susceptibility of rotavirus to bovine interferon in calf kidney cells. Arch. Virol. 1980;64:167–170. doi: 10.1007/BF01318020. [DOI] [PubMed] [Google Scholar]
  • 70.Landolfo S., Cafano F., Giovarelli M., Prat M., Cavallo G., Forni G. Inhibition of interferon-gamma may suppress allograft reactivity by T lymphocytes in vitro and in vivo. Science. 1985;229:176–179. doi: 10.1126/science.3160110. [DOI] [PubMed] [Google Scholar]
  • 71.Langford M.P., Villarreal A.L., Stanton G.J. Antibody and interferon act synergistically to inhibit enterovirus, adenovirus and herpes simplex virus infection. Infect. Immun. 1983;41:214–218. doi: 10.1128/iai.41.1.214-218.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.LeBleu R., Sen G.C., Shaila S., Cabrer B., Lengyel P. Second ed. Vol. 73. 1976. Interferon, dsRNA and protein phosphorylation; pp. 3107–3111. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Lefkowitz S.S., Luna V.E.R. Priming of bovine interferons. Intervirology. 1984;21:221–223. doi: 10.1159/000149523. [DOI] [PubMed] [Google Scholar]
  • 74.Leibson H.J., Gefter M., Zlotnik A., Marrack P., Kappler J.W. Role of γ-interferon in antibody producing responses. Nature (London) 1984;309:799–801. doi: 10.1038/309799a0. [DOI] [PubMed] [Google Scholar]
  • 75.LeJan C., Asso J. The local and systemic immune response of calves following experimental infection with IBR virus. Adv. Exp. Med. Biol. 1981;137:677–692. [PubMed] [Google Scholar]
  • 76.Lengyel P. Biochemistry of interferons and their actions. Ann. Rev. Biochem. 1982;51:251–282. doi: 10.1146/annurev.bi.51.070182.001343. [DOI] [PubMed] [Google Scholar]
  • 77.Letchworth G.J., Carmichael L.E. Production of interferon by bovine peripheral blood monocytes infected with bovid herspesvirus 2. Vet. Microbiol. 1983;8:69–80. doi: 10.1016/0378-1135(83)90020-2. [DOI] [PubMed] [Google Scholar]
  • 78.Letchworth G.J., Carmichael L.E. The effect of temperature on production and function of bovine interferons. Arch. Virol. 1984;82:211–221. doi: 10.1007/BF01311164. [DOI] [PubMed] [Google Scholar]
  • 79.Leung D.W., Capon D.J., Goeddel D.V. The structure and bacterial expression of three distinct bovine interferon β genes. Biotechnology (May) 1984:458–464. [Google Scholar]
  • 80.Lipscomb M.P., Toews G.B., Lyons G.R., Uhr J.W. Antigen presentation by guinea pig alveolar macrophages. J. Immunol. 1981;126:286–291. [PubMed] [Google Scholar]
  • 81.Maheshwari R.K., Demsey A.E., Mohanty S.B., Friedman R.M. Second ed. Vol. 77. 1980. Interferon treated cells release vesicular stomatitis virus particles lacking glycoprotein spikes: correlation with biomedical data; pp. 2287–2287. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Merigan T.C., Friedman R.M., Fox C.F., editors. Second ed. 1982. p. 25. (Interferons UCLA Symp. Mol. Cell Biol.). [Google Scholar]
  • 83.Nilsen T.W., Wood D.L., Baglioni C. Virus-specific effects of interferon in embryonal orcinoma cells. Nature (London) 1980;286:178–180. doi: 10.1038/286178a0. [DOI] [PubMed] [Google Scholar]
  • 84.Pestka S. The human interferons - from protein purification and sequence to cloning and expression in bacteria: before, between and beyond. Arch. Biochem. Biophys. 1983;221:1–37. doi: 10.1016/0003-9861(83)90118-2. [DOI] [PubMed] [Google Scholar]
  • 85.Peterhans E., Charrey J., Richoz Y., Wyler R. Production of large quantities of interferon with calf testicular cells and leukocytes. Res. Vet. Sci. 1976;20:99–100. [PubMed] [Google Scholar]
  • 86.Preble O.T., Friedman R.M. Biology of disease. Interferon-induced alterations in cells: relevance to viral and non-viral diseasesLab. Invest. 1983;49:4–18. [PubMed] [Google Scholar]
  • 87.Ransohoff R.M., Maroney P.A., Nayak D.P., Chambers T.M., Nilsen T.W. Effect of human alpha A interferon on influenza virus replication in MDBK cells. J. Virol. 1985;56:1049–1052. doi: 10.1128/jvi.56.3.1049-1052.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Rinaldo C.R., Isackson D.W., Overall J.C., Glasgow L.A., Brown T.T., Bistner S.I., Gillespie J.H., Scott F.W. Fetal and adult bovine interferon production during bovine viral diarrhea virus infection. Infect. Immun. 1976;14:660–666. doi: 10.1128/iai.14.3.660-666.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Roberts W.K., Hovanessian A., Brown R.E., Clemens M.J., Kerr B.M. Interferon-mediated protein kinase and low-molecular weight inhibitor of protein synthesis. Nature (London) 1976;264:477–480. doi: 10.1038/264477a0. [DOI] [PubMed] [Google Scholar]
  • 90.Roney C.S., Rossi C.R., Smith P.C., Lauerman L.C., Spano J.S., Hanrahan L.A., William J.C. Effect of human leukocyte A interferon on prevention of infectious bovine rhinotracheitis virus infection in cattle. Am. J. Vet. Res. 1985;46:1251–1255. [PubMed] [Google Scholar]
  • 91.Rosenquist B.D. Polyriboinosinic-polyribocytidylic acid induced interferons in calves. Am. J. Vet. Res. 1971;32:35–39. [PubMed] [Google Scholar]
  • 92.Rosenquist B.D. Induction and biological significance of interferon with particular reference to cattle. Am. Vet. Med. Assoc. 1973;163:821–824. [Google Scholar]
  • 93.Rosenquist B.D., Loan R.W. Production of circulating interferon in the bovine species. Am. J. Vet. Res. 1969;30:1293–1303. [PubMed] [Google Scholar]
  • 94.Rosenquist B.D., Loan R.W. Interferon induction in the bovine species by infectious bovine rhinotracheitis. Am. J. Vet. Res. 1969;30:1305–1312. [PubMed] [Google Scholar]
  • 95.Rossi C.R., Kiesel G.K. Factors affecting the production of bovine type I interferon on bovine embryonic lung cells by polyriboinosinic-polyribocytidylic acid. Am. J. Vet. Res. 1980;41:557–560. [PubMed] [Google Scholar]
  • 96.Rossi C.R., Kiesel G.K., Hoff E.J. Factors affecting the assay of bovine type I interferon on bovine embryonic lung cells. Am. J. Vet. Res. 1980;41:552–556. [PubMed] [Google Scholar]
  • 97.Rothermel C.D., Rubin B.Y., Murray H.W. γ-interferon is the factor in lymphokine that activates human macrophages to inhibit intracellular chlamydia psittaci replications. J. Immunol. 1983;131:2542–2544. [PubMed] [Google Scholar]
  • 98.Rouse B.T. Role of neutrophils in antiviral immunity. Adv. Exp. Med. Biol. 1981;137:263–278. [PubMed] [Google Scholar]
  • 99.Rouse B.T., Babiuk L.A., Henson P.M. Neutrophils in antiviral immunity. Induction of an interferon-like inhibitor by herpesviruses in bovine neutrophilsJ. Infect. Dis. 1979;141:223–232. doi: 10.1093/infdis/141.2.223. [DOI] [PubMed] [Google Scholar]
  • 100.Rudenko V.I., Smorodintsev A.A., Aksenov O.A., Lyabina L.M. The nature of interferon-producing cells. Vopr. Virusol. 1970;15:52–56. [PubMed] [Google Scholar]
  • 101.Savan M., Angulo A.B., Derbyshire J.B. Interferon, antibody responses and protection induced by an intranasal infectious bovine rhinotracheitis vaccine. Can. Vet. J. 1979;20:207–210. [PMC free article] [PubMed] [Google Scholar]
  • 102.Schellekens H., Weimar M., Cantell K., Stitz L. Antiviral effect of interferon in vivo may be mediated by the host. Nature (London) 1979;278:742. doi: 10.1038/278742a0. [DOI] [PubMed] [Google Scholar]
  • 103.Schwers A., van den Broecke C., Goossens A., Maenhoudt M., Bugyaki L., Pastoret P.P., Werenne J. Administration of human interferon to young calves: circulating antiviral activity and biological response of the host. Arch. Int. Physiol. Biochem. 1982;90:B214–B215. [Google Scholar]
  • 104.Sellers R.F., Fitzpatrick M. An assay of interferon produced in rhesus monkey and calf kidney tissue culture using bovine enterovirus M6 as challenge. Brit. J. Exp. Pathol. 1962;43:674–683. [PMC free article] [PubMed] [Google Scholar]
  • 105.Sehgal P.B. The interferon genes. Biochim. Biophys. Acta. 1982;695:17–33. doi: 10.1016/0304-419x(82)90004-x. [DOI] [PubMed] [Google Scholar]
  • 106.Sidman C.L., Marshall J.D., Shultz L.D., Gray P.W., Johnson H.H. γ-interferon is one of several direct B cell maturing lymphokines. Nature (London) 1984;309:801–804. doi: 10.1038/309801a0. [DOI] [PubMed] [Google Scholar]
  • 107.Smorodintsev A.A. The production and effect of interferon in organ cultures of calf trachea. Br. J. Exp. Pathol. 1968;49:511–515. [PMC free article] [PubMed] [Google Scholar]
  • 108.Stewart W.C., Gosser L.B., Lockhart R.Z. Priming: A non-viral function of interferons. J. Virol. 1971;7:792–801. doi: 10.1128/jvi.7.6.792-801.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Stewart W.E. II, editor. Second ed. Springer Verlag; New York: 1979/1981. (The Interferon System). [Google Scholar]
  • 110.Straub O.C., Ahl R. Lokale Interferonbildung beim Rind nach intranasaler Infektion mit Avirulentem IBR/IPV-virus und deren Wirkung auf eine anschliessende Infektion mit Maulund Klauenseuche-virus. Abl. Vet. Med. B. 1976;23:470–482. [PubMed] [Google Scholar]
  • 111.Theil K.W., Mohanty S.B., Hetrick F.M. Vol. 137. 1971. Effect of poly I:C on infectious bovine rhinotracheitis virus infection in calves; pp. 1176–1179. (Proc. Soc. Exp. Biol. Med.). [DOI] [PubMed] [Google Scholar]
  • 112.Thely M., Choay J., Dhennin L., Dhennin L. Virostase induite in vivo par des acides ribonucléiques non-infectieux. C. R. Acad. Sci. 1963;256:1048–1050. [PubMed] [Google Scholar]
  • 113.Todd J.D., Volenec F.J., Paton I.M. Interferon in nasal secretions and sera of calves after intranasal administration of avirulent infectious bovine rhinotracheitis virus: association of interferon in nasal secretions with early resistance to challenge with virulent virus. Infect. Immun. 1972;5:699–706. doi: 10.1128/iai.5.5.699-706.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Toews G.B., Vial W.C., Dunn M.M. The accessory cell function of human alveolar macrophages in specific T cell proliferation. J. Immunol. 1984;132:181–186. [PubMed] [Google Scholar]
  • 115.Tovey M.G., Bandu M.-T., Began-Lours J., Brouty-Boye D., Gresser I. Antiviral activity of bovine interferons on primate cells. J. Gen. Virol. 1977;36:341–344. doi: 10.1099/0022-1317-36-2-341. [DOI] [PubMed] [Google Scholar]
  • 116.Trueblood M.S., Manjara J. Response of bovine viruses to interferon. Cornell Vet. 1972;62:3–12. [PubMed] [Google Scholar]
  • 117.Tyrrell D.A.J. Interferon produced by cultures of calf kidney cells. Nature (London) 1959;184:452–453. doi: 10.1038/184452a0. [DOI] [PubMed] [Google Scholar]
  • 118.van den Broecke C., Schwers A., Dagenais L., Goossens A., Maenhoudt M., Pastoret P.P., Werenne J. Interferon response in colostrum-deprived newborn calves infected with bovine rotavirus: Its possible role in the control of the pathogenicity. Ann. Rech. Vet. 1984;15:29–34. [PubMed] [Google Scholar]
  • 119.Werenne J. Use of exogenous interferon in man and animals. In quest of an antiviral of broad veterinary use. In: Cancellotti F.M., Galassi D., editors. Adjuvant Interferon and Non-specific Immunity. 1984. pp. 17–30. (Comm. Eur. Commun.). (EUR 8675EN) [Google Scholar]
  • 120.Werenne J. Pergamon Press; London, U.K: 1985. Interferon in veterinary medicine: the present position and future prospects. (Outlook on Agriculture). [Google Scholar]
  • 121.Whitaker-Dowling P.A., Wilcox D.K., Widnell C.C., Younger J.S. Vol. 80. 1983. Interferon-mediated inhibition of virus penetration; pp. 1083–1086. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Wilson V., Jeffreys A.J., Barrie P.A., Boseley P.G., Slocombe P.M., Easton A., Burke D.C. A comparison of vertebrate interferon gene families detected by hydridization with human interferon DNA. J. Mol. Biol. 1982;166:457–475. doi: 10.1016/s0022-2836(83)80281-2. [DOI] [PubMed] [Google Scholar]
  • 123.Zawatzky R., DeMaeyer E., DeMaeyer-Guignard J. Vol. 82. 1985. Identification of individual interferon-producing cells by in situ hybridization; pp. 1136–1140. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Zawatzky R., Hilfenhaus J., Marcucci F., Kirchner H. Experimental infection of inbred mice with herpes simplex virus. I. Investigation of humoral and cellular immunity and of interferon induction. J. Gen. Virol. 1981;53:31–38. doi: 10.1099/0022-1317-53-1-31. [DOI] [PubMed] [Google Scholar]
  • 125.Zilberstein A., Federman P., Shulman L., Revel M. Specific phosphorylation in vitro of a protein associated with ribosomes of interferon-treated mouse L-cells. FEBS Lett. 1976;68:119–124. doi: 10.1016/0014-5793(76)80418-8. [DOI] [PubMed] [Google Scholar]
  • 126.Zygraich N. Nasale Interferonbildung nach Impfung mit einem temperaturspecifischen Parainfluenza-3-virus. Tieraerztl. Umsch. 1984;39:127–128. [Google Scholar]

Articles from Antiviral Research are provided here courtesy of Elsevier

RESOURCES